Cue Biopharma, Inc. (CUE) › Operating IncomeCue Biopharma, Inc. (CUE) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2017: -$23.23M2018: -$38.70M2019: -$36.77M2020: -$45.04M2021: -$43.71M2022: -$53.23M2023: -$52.15M2024: -$41.50M2025: -$26.55M-$26.55M2017Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$26.55M+36.0%2024-$41.50M+20.4%2023-$52.15M+2.0%2022-$53.23M-21.8%2021-$43.71M+3.0%2020-$45.04M-22.5%2019-$36.77M+5.0%2018-$38.70M-66.6%2017-$23.23M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share